UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED Universal Health International Group Holding Limited Stock
Equities
2211
KYG9302L1106
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.062 HKD | -1.59% |
|
+6.90% | -37.37% |
| Sales 2022 | 1.27B 176M 1.38B | Sales 2023 | 1.3B 179M 1.4B | Capitalization | 72.28M 9.99M 78.18M |
|---|---|---|---|---|---|
| Net income 2022 | -188M -25.98M -203M | Net income 2023 | -105M -14.51M -114M | EV / Sales 2022 | 0.04 x |
| Net cash position 2022 | 18.63M 2.57M 20.15M | Net cash position 2023 | 2.94M 406K 3.18M | EV / Sales 2023 | 0.05 x |
| P/E ratio 2022 |
-0.31
x | P/E ratio 2023 |
-0.6
x | Employees | 1,617 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.22% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -7.94% | ||
| Current month | -13.43% | ||
| 1 month | -10.77% | ||
| 3 months | -36.96% | ||
| 6 months | -40.21% | ||
| Current year | -41.41% |
1 week
0.05
0.07
1 month
0.050.09
Current year
0.050.11
1 year
0.050.20
3 years
0.050.40
5 years
0.051.77
10 years
0.0555.80
| Managers | Title | Age | Since |
|---|---|---|---|
Chuan Fu Chu
CEO | Chief Executive Officer | 53 | - |
Ze Hua Zhao
DFI | Director of Finance/CFO | 56 | 04-12-31 |
Kit Ying Hui
SEC | Corporate Secretary | - | 23-09-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 77 | 13-11-17 | |
Dong Kun Jin
FOU | Founder | 51 | 12-03-11 |
Chuan Fu Chu
CEO | Chief Executive Officer | 53 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 0.062 | -1.59% | 152 300 |
| 24-04-15 | 0.063 | +18.87% | 345,000 |
| 24-04-12 | 0.053 | -11.67% | 343,000 |
| 24-04-11 | 0.06 | +5.26% | 140,000 |
| 24-04-10 | 0.057 | -1.72% | 107,400 |
Delayed Quote Hong Kong S.E., April 15, 2024 at 11:30 pm EDT
More quotes
Universal Health International Group Holding Limited is an investment holding company principally engaged in the distribution and retail of drugs and other pharmaceutical products in the northeastern region of the People's Republic of China (the PRC). The Company operates its business through four segments: Distributions, Retails I, Retails II and Others. The Others segment is engaged in investment business. Through its subsidiaries, the Company is also engaged in e-commerce and trading of health-care products.
Sector
Pharmaceuticals
Calendar
2024-09-25
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -41.41% | 4.51M | |
| +12.89% | 68.73B | |
| +6.18% | 25.56B | |
| -4.25% | 7.74B | |
| +3.53% | 7.68B | |
| -28.85% | 7.01B | |
| +2.26% | 4.65B | |
| +19.12% | 4.23B | |
| 0.00% | 4.03B | |
| -2.96% | 3.86B |
- Stock Market
- Equities
- 2211 Stock
